Modeling neutral viral mutations in the spread of SARS-CoV-2 epidemics

  title={Modeling neutral viral mutations in the spread of SARS-CoV-2 epidemics},
  author={Vitor M Marquioni and M. D. de Aguiar},
  journal={PLoS ONE},
Although traditional models of epidemic spreading focus on the number of infected, susceptible and recovered individuals, a lot of attention has been devoted to integrate epidemic models with population genetics. Here we develop an individual-based model for epidemic spreading on networks in which viruses are explicitly represented by finite chains of nucleotides that can mutate inside the host. Under the hypothesis of neutral evolution we compute analytically the average pairwise genetic… Expand


Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China
An estimation of the clinical severity of COVID-19, based on the data available so far, can help to inform the public health response during the ongoing SARS-CoV-2 pandemic. Expand
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Human airway epithelial cells were used to isolate a novel coronavirus, named 2019-nCoV, which formed a clade within the subgenus sarbecovirus, Orthocoronavirinae subfamily, which is the seventh member of the family of coronaviruses that infect humans. Expand
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.
This review discusses current evidence regarding the pathophysiology, transmission, diagnosis, and management of COVID-19, the novel severe acute respiratory syndrome coronavirus 2 pandemic that has caused a worldwide sudden and substantial increase in hospitalizations for pneumonia with multiorgan disease. Expand
Quantifying the effects of quarantine using an IBM SEIR model on scalefree networks
It is shown that relatively short and intense quarantine periods can also be very effective in flattening the infection curve and even killing the virus, but the likelihood of such outcomes are low. Expand
Localization, epidemic transitions, and unpredictability of multistrain epidemics with an underlying genotype network.
This work introduces a disease model with an underlying genotype network to account for two important mechanisms, and illustrates the richness of behaviours that are possible even in well-mixed host populations once the authors consider strain diversity and go beyond the "one disease equals one pathogen" paradigm. Expand
COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing
  • K. To, I. Hung, +17 authors K. Yuen
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2020
The results suggest SARS-CoV-2 may continue to circulate among the human populations despite herd immunity due to natural infection or vaccination, and further studies of patients with re-infection will shed light on protective correlates important for vaccine design. Expand
Developing Covid-19 Vaccines at Pandemic Speed.
Developing Covid-19 Vaccines at Pandemic Speed An ideal vaccine platform would support development from viral sequencing to clinical trials in less than 16 weeks, demonstrate elicitation of consistency in clinical trials and support development of new vaccines at pandemic speed. Expand
Emergence of genomic diversity and recurrent mutations in SARS-CoV-2
The results are in line with previous estimates and point to all sequences sharing a common ancestor towards the end of 2019, supporting this as the period when SARS-CoV-2 jumped into its human host. Expand
Epidemic Data for Novel Coronavirus COVID-19; 2020. Wolfram Data Repository
  • 2020
Epidemiological characteristics of novel coronavirus infection: A statistical analysis of publicly available case data
Estimating the actual number of COVID-19 cases in Hokkaido Prefecture and Sapporo City using data on cases diagnosed outside these areas provided insight into the possible scope of undetected transmission. Expand